New Frontiers in Anti-Atherosclerotic Therapies
March 13, 2010
The Georgia World Congress Center
This event is complimentary
This event is not part of the official ACC Annual Scientific Session and/or the ACC’s Innovation in Intervention: i2 Summit in Partnership with the Cardiovascular Research Foundation, as planned by their Program Committees.
This course will review new therapeutic targets for atherosclerotic cardiovascular disease.
Physicians and Nursing staff involved in prevention of cardiovascular disease
As a result of attending this symposium, the participant will be able to do the following:
- Classify benefit of targeting risk factors.
- Distinguish degree of residual risk despite risk factor modification.
- Review novel therapeutic strategies.
|Stephen Nicholls, MBBS, PhD
|Steven Nissen, MD
Christie Ballantyne, MD
Philip Barter, MD, PhD
Bryan Brewer, MD
Alan Daugherty, PhD
Michael Davidson, MD
John Kastelein, MD, PhD
|SATURDAY, MARCH 6, 2010|
|Chairs||Steven Nissen, MD & Stephen Nicholls, MBBS, PhD|
|7:00 am||Continental Breakfast|
|8:00 am||Welcome - Stephen Nicholls, MBBS, PhD|
|8:10 am||Atherosclerosis Imaging: What Have We Learned? - Steven Nissen, MD|
|8:35am||LDL: How Low Should We Go? - Michael Davidson, MD|
|9:00 am||CETP Inhibition: Will It Work? - Philip Barter, MD, PhD|
|9:25 am||Infusion of HDL Mimetics - Bryan Brewer, MD|
|10:15 am||Induction of APOA-I Synthesis - John Kastelein, MD, PhD|
|10:40 am||LP-PLA2 Inhibition - Christie Ballantyne, MD|
|11:05 am||Renin Inhibition as an Anti-Atherosclerotic Strategy - Alan Daugherty, MD|
|11:30 am||Slowing Disease Progression: What Does It Mean? - Stephen Nicholls, MBBS, PhD|
|11:55 am||Wrap-Up - Steven Nissen, MD|
|Time for questions and answers will be included in each presentation.|
Georgia World Congress Center
285 Andrew Young International Blvd., NW
Atlanta, Georgia 30313-1591
The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus.
The Cleveland Clinic Foundation Center for Continuing Education fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify Jamie Belkin at 216.932.3448 at least two weeks prior to the activity.
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.